WebSpecial Instructions for Trabectedin (Yondelis®) Page 2 of 2 Developed by Dana-Farber Cancer Institute Last Revised 01/2016 Patient and Family Education Committee Four … Webトラベクテジン （trabectedin）は 抗腫瘍薬 の一つ。 Ecteinascidin 743 （エクテイナシジン743）あるいは ET-743 としても知られている。 商品名は ヨンデリス 。 悪性軟部腫瘍 の治療薬として日本 [1] 、アメリカ、 ヨーロッパ 、 ロシア などで承認されている。 また、 乳癌 、 前立腺癌 、小児肉腫に対する 治験 が行われている。 トラベクテジンは 欧州 …

YONDELIS for CPK more than 2.5 times the upper limit of …

WebAssess neutrophil count prior to administration of each dose of YONDELIS and periodically throughout the treatment cycle. Withhold or reduce dose of YONDELIS based on severity of adverse reaction [see Dosage and Administration (2.3)]. 5.2 . Rhabdomyolysis . YONDELIS can cause rhabdomyolysis and musculoskeletal toxicity. In Trial ET743-SAR-3007, WebYONDELIS®is administered as an intravenous infusion over 24 hours through a central venous line every 21 days (3 weeks), until disease progression or unacceptable toxicity. YONDELIS®may be administered to inpatients or outpatients, via stationary or ambulatory pump, at the physician’s discretion. foldable outdoor high chair

207953Orig1s000 - Food and Drug Administration

WebSep 25, 2012 · A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for … WebYONDELIS ® is the only treatment approved specifically for unresectable or metastatic liposarcoma or leiomyosarcoma after an anthracycline-containing regimen 1-3 SAFETY Established in 6 open-label, single-arm trials, and … WebTrabectedin (Yondelis ®) is used to treat soft tissue sarcoma and sometimes ovarian cancer . It may sometimes be used to treat other cancers. It is best to read this … foldable outdoor island buffet